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Introduction
Rap1 has been implicated in the control of cell adhesion in a 
  variety of cell types (Stork, 2003; Bos, 2005; Kinashi and 
  Katagiri, 2005; Retta et al., 2006). In mammalian cells, Rap1 
controls cell spreading by mediating the functions of integrins, 
by binding to and localizing the Rac exchange factors (guanine 
nucleotide exchange factors [GEFs]) VAV1 and TIAM1 to the 
sites of cell spreading, and by regulating cadherin-mediated 
cell–cell contacts (Bos et al., 2003; Arthur et al., 2004; Enserink 
et al., 2004; Fukuyama et al., 2005; Kinashi and Katagiri, 2005; 
Fukuhra et al., 2006). Rap1 is thought to control cell adhesion 
and the leading edge function of moving cells by interacting 
with and regulating adaptor proteins that help control the cyto-
skeleton, although there is no direct evidence of a regulatory 
role for Rap1. RIAM and lamellipodin are related members of 
the MRL family of adaptor proteins containing a Ras asso-
ciation (RA) Rap1-GTP–binding domain, a PI(3,4)P2-binding 
pleckstrin homology (PH) domain, and a polyproline domain 
that interacts with Ena–vasodilator-stimulated phosphoprotein 
and profi  lin. RIAM1 induces cell spreading and lamellipodia 
formation and localizes to the sites of membrane protrusion 
(Lafuente et al., 2004), whereas lamellipodin controls leading 
edge formation and fi  lamentous actin (F-actin) polymerization 
in PDGF-treated fi  broblasts (Krause et al., 2004). Other Rap1 
effectors include the following: affi  din, which is associated with 
cell junctions and binds ZO-1, nectins, and profi  lin and, thus, 
may provide a link between Rap1 and the regulation of F-actin 
fi  laments (Asakura et al., 1999); RapL, which binds LFA-1 
(lymphocyte function–associated antigen 1) and regulates LFA-1 
localization in a Rap1-GTP–dependent manner (Fujita et al., 
2005); ARAP3, which contains an Arf6 GTPase-activating 
  protein, a RhoA GTPase-activating protein domain, and several 
PH domains and affects PDGF-induced lamellipodia formation 
(Krugmann et al., 2006); and PDZ-GEF, a Rap1-GTP–binding 
Rap1-GEF (Rebhun et al., 2000; Lee et al., 2002).
In Dictyostelium discoideum, Rap1 has been linked to 
  cytoskeletal regulation, phagocytosis, and the response to osmotic 
stress (Rebstein et al., 1993, 1997; Kang et al., 2002). The over-
expression of wild-type Rap1 leads to cell spreading and re-
duces the contraction of cells in response to treatment with 
azide. The reduction of Rap1 expression suppresses osmotic 
stress–induced cyclic guanosine monophosphate (cGMP) pro-
duction and impairs cell viability, whereas the expression of 
constitutively active Rap1
G12V enhances cGMP production 
(Kang et al., 2002). Osmotic stress causes the activation of Rap1 
with kinetics paralleling those of cGMP production. Rap1 was 
implicated in phagocytosis by an analysis of the   putative Rap1 
effector Phg2, a kinase with an RA domain that preferentially 
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binds Rap1-GTP but not Ras-GTP (Gebbie et al., 2004). This 
phg2-null strain exhibits defects in parti  cle  binding during 
phagocytosis, cell substratum adhesion, and motility.
The mechanisms by which Rap1 controls cytoskeletal re-
organizations in D. discoideum are not understood. To investi-
gate this, we analyzed the role of Rap1 in cell adhesion and 
chemotaxis and found that Rap1 controls myosin II assembly 
and disassembly. We demonstrate that Rap1 is activated at the 
cell’s cortex and preferentially at the leading edge of chemo-
taxing cells, the site at which Phg2 localizes. Cells expressing 
constitutively active Rap1 are unable to effectively regulate 
  myosin II assembly and disassembly. We determined that Phg2 
is required for myosin II phosphorylation in an in vitro assay. 
Our fi  ndings suggest a model in which localized recruitment 
to and activation of Phg2 at the leading edge by Rap1-GTP of 
chemotaxing cells are required for proper myosin II phosphoryl-
ation and disassembly at the newly formed pseudopod. We sug-
gest that this leading edge activation of Rap1 regulates cell 
adhesion and, during chemotaxis, helps establish cell polarity 
by locally modulating myosin II assembly and disassembly.
Results
Rap1 is activated in response 
to chemoattractant stimulation
D. discoideum has a single Ras subfamily member that is homo-
logous to human Rap1 (Weeks et al., 2005). We investigated 
whether D. discoideum Rap1 plays a role in chemotaxis by 
  examining kinetics of the chemoattractant (cAMP)-mediated 
activation of endogenous Rap1 and myc-tagged wild-type, 
constitutively active (Rap1
G12V), and dominant-negative 
D. discoideum Rap1 (Rap1
S17N) expressed in D. discoideum cells. 
We used a pull-down assay using the human RalGDS Rap1-
GTP–binding domain, which shows high but not exclusive 
specifi  city for the GTP-bound form of Rap1 and only poorly 
binds Ras-GTP in crude extracts in this assay (Fig. 1 E; see 
Materials and methods; Herrmann et al., 1996; Franke et al., 
1997). Fig. 1 A shows that endogenous Rap1 was rapidly 
activated in response to stimulation, with a peak at 5–10 s. 
Myc-Rap1 (Rap1
OE) expressed in wild-type cells displayed a 
similar activation profi  le (Fig. 1 A). There was a high level of 
Figure 1.  Activation of Rap1 by cAMP. (A) The activation level of endogenous Rap1 (open arrow) or myc-Rap1 (closed arrow) in response to cAMP was 
assayed using a GST-RapBD pull-down assay (see Materials and methods). Wild-type cells or cells expressing myc-Rap1 were stimulated with cAMP for the 
indicated times and analyzed by immunoblot assay using an antibody against Rap1. The data were quantitated by densitometry and normalized to total 
Rap1. (B) The translocation of RapBD-RalGDS-YFP to the membrane in response to uniform chemoattractant stimulation was imaged. (C) Translocation kinet-
ics of RapBD-RalGDS-YFP or GFP-RasBD were obtained from time-lapse recordings and quantitated as described previously (Sasaki et al., 2004). The 
graphs represent the mean of data on several cells from videos taken from at least three separate experiments. Error bars represent SD. (D) Spatial localiza-
tion of activated Rap1 in migrating cells. The asterisk indicates the position of the micropipette containing cAMP. (E) Lysates from cells expressing GFP fusion 
wild-type Rap1 (OE) or constitutive Rap1 (CA) were used in the pull-down assay using GST-RalGDS-RBD or GST-Raf1-RBD. The samples were subjected to 
SDS-PAGE and immunoblotted using an anti-GFP antibody or anti-pan Ras antibody.RAP1 CONTROL OF ADHESION AND CHEMOTAXIS • JEON ET AL. 1023
myc-Rap1
G12V in the GTP-bound form in unstimulated cells, 
and the level did not change on stimulation. Myc-Rap1
S17N, 
which was expressed at approximately the same level as myc-
Rap1
OE and myc-Rap1
G12V, did not exhibit binding before 
or after stimulation. The relative (normalized) level of endo-
genous Rap1-GTP (level of Rap1-GTP compared with total 
Rap1 as determined by Western blotting) was slightly reduced 
in cells expressing Rap1
S17N.
Spatial localization of activated Rap1
We investigated Rap1 localization using GFP-Rap1 and myc-
Rap1. GFP-Rap1 exhibited the same activation kinetics as endo-
genous Rap1 or myc-Rap1, indicating that it was biologically 
active (unpublished data). GFP-Rap1 and myc-Rap1 localized 
predominantly to intracellular membranes, including the ER 
and endosomal membranes, which is similar to observations in 
mammalian cells (Fig. 2, A–C; Berger et al., 1994; Ohba et al., 
2003; Bivona et al., 2004). In addition, a portion of GFP-Rap1 
was present on the plasma membrane. This is more readily seen 
after removal of the soluble cytoplasmic fraction (Fig. 2 F). 
  Total GFP-Rap1 showed a similar localization in chemotaxing 
cells and is absent from the domain immediately posterior to 
the leading edge, presumably because the endosomal membrane 
fraction is excluded by the pseudopodial F-actin cortex (Fig. 
2 E). The localization of total Rap1 is not detectably altered on 
global (uniform) chemoattractant stimulation (Fig. 2 D). GFP-
Rap1
G12V exhibited a similar subcellular localization (unpub-
lished data).
We created a YFP-RalGDS reporter to examine the spatial-
temporal activation of Rap1 (Bivona et al., 2004). We observed 
a low level of Rap1-GTP (localized YFP-RapBD) at the plasma 
membrane before chemoattractant stimulation, which is consis-
tent with a basal level of Rap1-GTP in these cells. In response 
to chemoattractant stimulation, Rap1-GTP levels at the cell cortex 
rapidly increase within 3 s of stimulation and peak at  6–8 s 
(Fig. 1, B and C). These Rap1 kinetics are slower than those of 
Ras (Fig. 1 C; Sasaki et al., 2004). In chemotaxing cells, Rap1-
GTP is found predominantly at the leading edge and extends 
weakly along the sides of cells (Fig. 1 D). This domain of Rap1-
GTP is broader than that observed for Ras-GTP (Sasaki et al., 
2004). No localization of the YFP-RapBD reporter is observed 
on vesicles and other intracellular membranes where the major-
ity of Rap1 is found, suggesting that Rap1-GTP activation is 
  restricted to the cortex.
Rap1 controls cell adhesion 
and regulates chemotaxis
Cells overexpressing wild-type Rap1 (Rap1
OE cells) are more 
fl  attened and spread than wild-type cells as previously described 
(Fig. 3 A; Rebstein et al., 1993, 1997). This phenotype is sub-
stantially enhanced in cells overexpressing Rap1
G12V and re-
duced in cells overexpressing Rap1
S17N (Fig. 3 A), suggesting 
that Rap1 may control cell-substratum attachment. This conclu-
sion was confi  rmed using cell-substratum attachment assays, 
which measure the fraction of cells that detach from a mem-
brane during agitation. Rap1-overexpressing cells exhibit a 
small increase in cell attachment (i.e., a decrease in cell detach-
ment; Fig. 3 B and Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200607072/DC1). The level of cell attachment 
is considerably greater for Rap1
G12V cells. We were unable to 
obtain a Rap1 knockout, suggesting that Rap1 is essential. To 
examine the phenotype of cells exhibiting reduced Rap1-GTP 
levels, we expressed Rap1
S17N in wild-type cells. Although ex-
pressing Rap1
S17N has little effect on endogenous Rap1 activa-
tion (Fig. 1 A), Rap1
S17N cells exhibit reduced attachment.
Unconventional myosin VII and talin A form a complex 
and are required for adhesion of cells to the substratum (Fig. 3 B; 
Niewohner et al., 1997; Tuxworth et al., 2005). We examined 
whether the overexpression of Rap1
G12V could bypass the talin A–
null cell defects. Overexpressing Rap1
G12V in talin A–null cells 
Figure 2.  Localization of Rap1. (A) GFP-
Rap1 in living cells. KAx-3 cells express-
ing GFP-Rap1 (RapOE), GFP-Rap1
G12V 
(RapCA), or GFP-Rap1
S17N (RapDN) were 
placed on glass coverslips and imaged 
with a laser-scanning confocal microscope. 
(B) Myc-Rap1 by indirect immunoﬂ  uores-
cence. Cells expressing myc-Rap1 proteins 
were ﬁ   xed with 3.7% formaldehyde and 
stained with anti-myc antibodies. Nuclei 
were visualized with DAPI. (C) GFP-Rap1 
on the endosomal membrane. Fluid-phase 
endosomes in the cells expressing GFP-Rap1 
proteins were labeled with TRITC-dextran. 
Dual-color confocal images were acquired. 
(D) Fluorescent images of an aggregation-
competent cell expressing GFP-Rap1 after 
uniform chemoattractant stimulation. Bar, 
5 μm. (E) GFP-Rap1 in the migrating cells. 
The asterisks indicate the direction of the 
micropipette. (F) GFP-Rap1 after the removal 
of cytoplasm. The soluble cytoplasm of 
cells expressing GFP-Rap1 was removed by 
breaking the plasma membrane using a micro-
pipette under a microscope. Images from 
the same cell were taken before or after 
  removal of the cytoplasm.JCB • VOLUME 176 • NUMBER 7 • 2007  1024
results in cells with a strong substratum attachment similar to 
that of wild-type cells overexpressing Rap1
G12V. This suggests 
that either Rap1 lies downstream of myosin VII–talin A or Rap1 
and myosin VII–talin A function in distinct pathways to control 
attachment and that Rap1
G12V can promote attachment indepen-
dently of talin A.
Wild-type cells become polarized and chemotax to a 
  micropipette emitting the chemoattractant cAMP with a high 
speed and chemotaxis index, an indicator of the directionality of 
movement (Fig. 3 C). Rap1
G12V cells move at <50% of the 
speed of wild-type cells and have a substantially decreased 
 chemotaxis index resulting from the production of lateral pseudo-
podia (and an increased number of turns) and the decreased 
  formation of a prominent leading edge in the direction of 
the chemoattractant gradient (Fig. 3 C and Fig. S2, available 
at http://www.jcb.org/cgi/content/full/jcb.200607072/DC1). 
Rap1
OE cells have a milder phenotype; Rap1
S17N has a speed and 
directionality similar to that of wild-type cells, although with a 
reduced number of turns and lateral pseudopodia (Fig. 3 C). 
Myc-Rap1
OE and myc-Rap1
G12V cells experience delayed multi-
cellular development as a result of a delay in aggregation and 
morphogenesis. The aggregates are also smaller than those of 
wild-type cells (Fig. S3). In contrast, Rap1
S17N cells develop 
more rapidly than wild-type cells.
Rap1 control of myosin and the cell cortex
Wild-type cells rapidly round up and contract after treatment 
with azide (NaN3) as described previously (Fig. 4 A; Pasternak 
et al., 1989; Kang et al., 2002). As shown in Fig. 4 A, cells 
overexpressing Rap1
G12V do not change shape after NaN3 treat-
ment, and, in agreement with a previous study, NaN3-mediated 
contraction does not occur in cells lacking myosin II (mhcA
− 
cells; Pasternak et al., 1989), suggesting an essential role for 
myosin II in this response. Fig. 4 (A and B) indicates that 
mhcA
− (myosin II null) cells exhibit a fl  attened, spread shape 
and a high degree of substratum attachment compared with 
wild-type cells. The attachment of mhcA
− cells is further in-
creased by overexpressing Rap1
G12V. These results suggest that 
Rap1 functions through myosin II and other pathways to con-
trol cell adhesion.
Figure 3.  Rap1 effects on cell morphology, adhesion, and chemotaxis. (A) Cell spreading by active Rap1. Aggregation-competent cells expressing myc-
Rap1 proteins. Arrows indicate ﬂ  attened and spread edges of the cells expressing Rap
G12V. (B) Cell-substratum adhesion assays were performed as de-
scribed in Materials and methods. Adhesion was measured by the ratio of detached cells compared with the total number of cells. Experiments were 
performed at least three times. Error bars represent SD. (C) Chemotaxis of the cells expressing Rap1. Cells were traced from the videos and analyzed using 
DIAS software. Representative stacked images are shown. Images taken every minute were superimposed. The asterisks indicate the positions of a micro-
pipette containing cAMP. The results of DIAS analysis are shown in the table. Speed indicates the speed of the cell’s centroid movement along the total path. 
Directionality is a measure of how straight the cells move, and direction change is a measure of the number and frequency of turns the cell makes. Round-
ness is an indication of the polarity of the cells. The number of newly formed pseudopodia was counted in every 6-s image for the 10-min time period.RAP1 CONTROL OF ADHESION AND CHEMOTAXIS • JEON ET AL. 1025
Myosin II assembly in D. discoideum is regulated by the 
differential phosphorylation of three Thr residues (Thr
1,823, 
Thr
1,833, and Thr
2,029) in the myosin II tail by a family of myosin 
II heavy chain kinases (MHCKs; Pagh et al., 1984; Egelhoff 
et al., 1993; De la Roche et al., 2002; Yumura et al., 2005). 
  Unphosphorylated myosin II self-assembles, whereas myosin II is 
disassembled in vivo by phosphorylation by the MHCKs. Sub-
stitution of Thr
1,823, Thr
1,833, and Thr
2,029 with alanines (3XAla) 
leads to overassembled myosin II, whereas Asp substitutions 
(3XAsp) cause constitutively unassembled myosin II. As ex-
pected, mhcA
− cells expressing myosin II
3XAsp behave similarly 
to mhcA
− cells: they exhibited high attachment, are spread, and 
do not change shape upon NaN3 treatment (Fig. 4, A and B). In 
contrast,  mhcA
− cells expressing myosin II
3XAla are more 
rounded before NaN3 treatment and do not round further upon 
NaN3 treatment (Fig. 4 A), presumably because they are already 
contracted. These cells also exhibit less adhesion (Fig. 4 B).
Because of the similarity of phenotypes and properties of 
mhcA
− cells and cells expressing Rap1
G12V, we investigated the 
effect of Rap1 on the reorganization of the cytoskeleton in 
  response to chemoattractant stimulation. In wild-type cells, 
chemoattractant stimulation results in a rapid, transient phos-
phorylation of myosin II, causing a small but reproducible drop 
in assembled myosin II in the Triton X-100 pellet after  5–10 s 
(Fig. 4 C). This response is followed by an  2.0–2.5-fold 
  increase in cortical myosin II that peaks at  40 s (Liu and 
  Newell, 1991; Steimle et al., 2001; Park et al., 2004). Myosin II 
assembly is not visibly affected by overexpressing wild-type Rap1. 
Figure 4.  Rap1 control of myosin and the cell cortex. (A) Cell morphology after NaN3 treatment. Log-phase vegetative wild-type cells, cells expressing 
Rap1
G12V, mhca-null cells (mhcA
−), and mhca-null cells expressing the myosin heavy chain phosphorylation mutant 3XAsp or 3XAla were washed with oxy-
genated MES buffer and treated with sodium azide. (B) Cell adhesion assay of mhcA mutants in the presence of NaN3. (C) Kinetics of F-actin polymeriza-
tion and myosin II assembly in the Triton X-100–insoluble cytoskeletal fraction of wild-type cells and cells expressing myc-Rap1 in response to chemoattractant 
stimulation. (D) Delocalization and relocalization of GFP–myosin II to the cell cortex in response to uniform cAMP stimulation. GFP–myosin II was co-
expressed with myc-Rap1 proteins in wild-type KAx-3 cells. Cells were stimulated with cAMP, and the ﬂ  uorescence images were taken every second. Three 
representative frames are shown. (E) The ﬂ  uorescence intensity of membrane-localized GFP–myosin II was quantitated as in Fig. 1 C. Error bars represent 
SD. (F) Localization of GFP–myosin II in the migrating cells coexpressing myc-Rap1 proteins. Arrows indicate the direction of movement, and arrowheads 
indicate the GFP–myosin II–concentrated region in the cells expressing Rap
G12V. (G) Localization of GFP–myosin II on the bottom of cells coexpressing myc-
Rap1
G12V was visualized by confocal microscope (top). To visualize the endogenous myosin II at the bottom of the cells, membrane cytoskeletons attached 
on the glass coverslips were prepared as described by Yumura and Kitanishi-Yumura (1992). Cells expressing Rap1
G12V were placed on the polylysine-
coated glass coverslips and immunostained with anti–myosin II antibodies after removal of the top part of cell bodies. The same exposures were used for 
the images.JCB • VOLUME 176 • NUMBER 7 • 2007  1026
However, the overexpression of Rap1
G12V causes a major 
  alteration in chemoattractant-stimulated changes in assembled 
myosin II. After the small decrease in cortical myosin II levels, 
there is only a slight and gradual rise in assembled myosin II 
that reaches a fi  rst plateau of  20% of the level of myosin II in 
wild-type cells at 40 s, the time when assembled myosin II 
  levels peak in wild-type cells (Fig. 4 C). There is a secondary, 
slow rise in assembled myosin II after 60 s, reaching a level of 
 50–60% of that of assembled myosin II in wild-type cells at 
120 s. The response in wild-type cells returns to near basal 
  levels by 80 s.
We used GFP–myosin II expressed in mhcA
− cells, which 
complements mhcA
− cell defects, to examine the changes in 
cortically localized myosin II in resting cells and in response to 
chemoattractant stimulation (Levi et al., 2002; Bosgraaf et al., 
2005). Unstimulated cells exhibit a basal level of GFP–myosin 
II at the cell cortex (Fig. 4, D and E). Upon chemoattractant 
stimulation, after a lag of a few seconds, there is a decrease in 
GFP– myosin II at the cortex with a minimum at  10 s fol-
lowed by an increase to above basal levels with a broad peak 
centered at 25–30 s and a subsequent decrease to basal levels. 
Rap1
OE cells have a similar response.
As with the assay that quantifi  es myosin II in the Triton 
X-100–insoluble fraction, Rap1
G12V cells exhibit an abnormal 
GFP–myosin II response (Fig. 4, D and E). At 5 s after stimula-
tion, the level of cortical GFP–myosin II decreases substantially. 
Although a minimum is reached at  10 s in wild-type cells, the 
level of cortical GFP–myosin II continues to decrease in 
Rap1
G12V cells with a low point at 15–20 s. Levels increase only 
slightly through 45 s. These data are consistent with a delayed 
and weak chemoattractant-mediated cortical accumulation of 
myosin II in cells overexpressing Rap1
G12V. Our fi  ndings sug-
gest that Rap1 directly or indirectly negatively regulates myosin 
II assembly at the cell cortex.
We used GFP–myosin II to study the spatial localization 
of myosin II in unstimulated vegetative cells and in developed 
cells chemotaxing to a micropipette. Wild-type cells have some 
cortically localized GFP–myosin II, and some cells have small 
patches of myosin II (Fig. 4 F). In contrast, vegetative Rap1
G12V 
cells are highly polarized, with one pole exhibiting a broad 
  domain of GFP–myosin II concentrated along the cortex. The 
other pole has a ruffl  ed front similar to what is sometimes 
observed at the leading edge of chemotaxing cells. We found 
that although wild-type cells have a very low level of myosin II 
Figure 5.  Subcellular localization of GFP-Phg2 and morphol-
ogy of phg2-null cells. (A) Translocation of GFP-Phg2 to the 
cell cortex in response to cAMP stimulation. The ﬂ  uorescence 
intensity on the plasma membrane fraction or in the cytosol 
fraction was quantitated using SimplePCI Imaging Systems. 
The graphs represent mean values of 10 cells from two sepa-
rate experiments. (B) Localization of GFP-Phg2 in the migrat-
ing cells. The arrow indicates the direction of movement. 
(C) Morphology of phg2-null cells. Vegetative cells were plated 
in HL5 growth medium or Na/K phosphate buffer on a plate 
with a hole covered by a glass coverslip and were imaged. 
phg2-null cells show lamellipodia-like (white arrows) or ﬁ  lopodia-
like structures (black arrows) compared with wild-type cells.RAP1 CONTROL OF ADHESION AND CHEMOTAXIS • JEON ET AL. 1027
(endogenous myosin II or GFP–myosin II) along the bottom of 
cells (Fig. 4 G), Rap1
G12V cells have a highly polarized myosin II 
localization along one pole of the cell. In chemotaxing wild-
type cells, myosin II localizes to the posterior and along the lat-
eral sides toward the cell’s posterior as reported previously 
(Clow and McNally, 1999). In Rap1
G12V cells, much of the myo-
sin II is found in a highly localized region at the very posterior 
of cells. These fi  ndings suggest that Rap1 may be involved in 
spatially restricting myosin II away from the leading edge in 
polarized cells.
Wild-type cells exhibit a biphasic F-actin polymerization 
profi  le with a sharp peak at 5 s and a second, lower, and broader 
peak at  45–60 s that has been linked to pseudopod extension 
(Fig. 4 C; Hall et al., 1989). Overexpressing Rap1
G12V results in 
an  40% increase in the basal level of F-actin. The kinetics of 
the response are similar to those of wild-type cells, with the 
level of F-actin proportionally higher in Rap1
G12V cells as a 
  result of the higher basal level of F-actin in unstimulated cells. 
The overexpression of wild-type Rap1 has little effect on the 
F-actin profi  le.
Regulation of Phg2, a Rap1 effector
The Phg2 Ser/Thr kinase was identifi  ed in a genetic screen for 
genes required for phagocytosis (Gebbie et al., 2004) and was 
identifi  ed independently by us in a yeast two-hybrid screen for 
proteins that interact with the PH domain–containing protein 
PhdB. Phg2 has an N-terminal PI(4,5)P2-binding domain, a 
Rap1-GTP–binding RA domain, and a Ser/Thr kinase domain 
and colocalizes with F-actin protrusions in vegetative cells 
(Gebbie et al., 2004; Blanc et al., 2005). We confi  rmed that the 
Phg2 RA domain preferentially binds Rap1-GTP over Ras-GTP 
(Gebbie et al., 2004; unpublished data).
We examined the subcellular localization of Phg2 using a 
GFP fusion (see Materials and methods). Fig. 5 A indicates that 
GFP-Phg2, which complements the phg2-null phenotypes (not 
depicted), exhibits a low level of cortical localization in unstim-
ulated cells. Upon chemoattractant stimulation, GFP-Phg2 rap-
idly and transiently translocates to the cell cortex. The level of 
cortical Phg2 peaks at  10 s. Phg2 localizes to the leading edge 
of polarized chemotaxing cells, with the localization extending 
weakly toward the posterior (Fig. 5 B). Thus, Phg2 shows a 
temporal and spatial localization similar to that of Rap1-GTP. 
This contrasts with Ras-GTP and PH domain proteins (e.g., 
CRAC and Akt/PKB) that are highly restricted to the leading 
edge and are absent from the lateral sides of chemotaxing cells 
(Sasaki et al., 2004). To determine whether the RA domain is 
required for the leading edge localization of Phg2 in chemo-
taxing cells, we created GFP-Phg2∆RA, a Phg2 construct lacking 
the RA domain. In chemotaxing cells, the localization of GFP-
Phg2∆RA was similar to that of GFP-Phg2, indicating that the 
RA domain is not required for Phg2 localization (Fig. 5 B). 
We also studied the possible mechanisms by which Phg2 is re-
cruited to the cortex. The localization is unaffected in cells 
treated with LY294002 and in cells lacking PI3K1 and PI3K2 
(pi3k1/2-null cells) nor is localization affected by pretreatment 
with the actin inhibitor latrunculin A (unpublished data). These 
results suggest that Phg2 localization is not controlled by the 
PI3K or F-actin pathways that mediate the leading edge local-
ization of several signaling components involved in the forma-
tion of a stable leading edge (Sasaki and Firtel, 2006).
To investigate the function of Phg2, we created a phg2-
null strain in our wild-type strain KAx-3 (see Materials and 
methods; unpublished data). phg2-null cells in either HL5 
axenic growth medium or phosphate buffer are very fl  at and 
spread compared with wild-type cells (and are not multinucle-
ated) and, like Rap1
G12V cells, often have large lamellipodia-like 
structures on one side of the cell (Rap1
G12V cells are shown as a 
comparison; Fig. 5 C). The cells often have numerous and more 
prominent fi   lipodia-like structures compared with wild-type 
cells, which are not observed in Rap1
G12V cells. The phenotypes 
were complemented by expressing GFP-Phg2 but not GFP-
Phg2∆RA. Collectively with the localization of GFP-Phg2∆RA, 
these data suggest that the RA domain and presumably Rap1-
GTP are required for Phg2 function but not its localization. We 
created a second phg2-null strain in which the Bsr selection cas-
sette was inserted in the opposite orientation. Both phg2-null 
strains had similar phenotypes that were complemented by 
  expressing tagged wild-type Phg2 (unpublished data).
Phg2 is required for regulation of cell 
adhesion and chemotaxis
Previous studies determined that phg2-null cells exhibit defects 
in particle binding, cell attachment, and basal cell motility 
when assayed in HL5 axenic growth medium (Gebbie et al., 
2004). We confi  rmed a decrease in the rate of phagocytosis in 
our phg2-null strain (unpublished data). Our phg2-null strain 
exhibited a very strong increase in cell attachment compared 
with our parental wild-type cells (Figs. 6 A and S1). These phe-
notypes were complemented by the expression of tagged Phg2 
in the phg2-null strain. There are confl  icting data concerning 
the cell adhesion of phg2-null cells. Gebbie et al. (2004) found 
that their phg2-null cells in a DH1 background exhibited  90% 
less adhesion compared with wild-type cells as assayed in a 
fl   ow chamber. Using a plate-shaking assay, Kortholt et al. 
(2006) showed that the same strain had a mildly reduced adhe-
sion. To confi  rm our data and to directly compare the two 
strains, we measured cell adhesion in the plate-shaking assay 
of Kortholt et al. (2006) (Fig. S1). These fi  ndings confi  rmed 
both our results and those of Kortholt et al. (2006) and demon-
strated an intrinsic difference between the two phg2-null strains 
and parental backgrounds. Our phg2-null strain phenotypes are 
fully complemented by GFP-Phg2, indicating that the pheno-
types result from the disruption of Phg2. Chemotaxing phg2-
null (phg2
KAx-3−) cells exhibit strong chemotaxis phenotypes. 
The cells move slower than wild-type cells, have a broader 
leading edge than wild-type cells, and produce numerous 
dominant lateral pseudo  podia and more pronounced smaller 
projections from the leading edge (Fig. 6, B–D). These pheno-
types are complemented by   expressing GFP- or GST-Phg2 
in phg2-null cells.
As shown in Fig. 6 E and Fig. S4 (available at http://www
.jcb.org/cgi/content/full/jcb.200607072/DC1), F-actin levels 
were  1.5-fold higher in unstimulated phg2-null cells compared 
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phg2-null cells showed only a small fi  rst peak of F-actin poly-
merization relative to wild-type cells, which had a 2.2-fold in-
crease. A small second peak was observed at  40 s. This overall 
reduced level of F-actin polymerization might account for 
the reduced speed of phg2-null cell chemotaxis. Unstimulated 
phg2-null cells had  30% more myosin II in the Triton X-100 
pellet compared with wild-type cells (Fig. 6 E). Upon stimula-
tion, phg2-null cells exhibited a small decrease in myosin II 
levels at  5 s and a subsequent peak at  40 s, which were 
changes similar to those in wild-type cells.
Our F-actin and myosin II assays used developed cells 
that are stimulated in suspension, whereas our attachment as-
says were performed with vegetative cells adhered to a substratum. 
Therefore, we examined whether the differences in the basal 
levels of F-actin and cortical myosin II between strains found in 
suspension assays are also representative of adherent cells. As 
depicted in Fig. S4, the data are similar to those obtained from 
developed cells in suspension.
Phg2 is required for cortical myosin II 
phosphorylation in vitro
To study the regulation of myosin II associated with the cortex 
in phg2-null cells, we examined the spatial-temporal localization 
of GFP–myosin II in vivo. Myosin II does not delocalize from 
the cortex in response to chemoattractant stimulation (unpub-
lished data). As myosin II dissociation depends on myosin II 
phosphorylation (De la Roche et al., 2002), this   observation 
suggested that Phg2 might regulate myosin II phosphorylation.
Gebbie et al. (2004) demonstrated that the expression of 
Phg2 in Escherichia coli led to the in vivo phosphorylation of 
bacterial proteins on Ser/Thr residues, indicating that Phg2 has 
Ser/Thr kinase activity. However, Phg2 purifi  ed from bacteria 
did not exhibit kinase activity under the conditions assayed. To 
examine Phg2 kinase activity, we expressed GFP- and GST-
tagged Phg2 in phg2-null cells and found that both proteins 
complemented the Phg2 chemotaxis and attachment defects. 
Triton X-100 lysates of cells before and at various times after 
chemoattractant stimulation were fractionated into soluble (10K 
supernatant) and insoluble (cortical) fractions, which were as-
sayed for potential Phg2 activity. For the soluble fraction, we 
purifi  ed Phg2 (GFP-Phg2 by immunoprecipitation and GST-
Phg2 on glutathione–Sepharose beads) and assayed for kinase 
activity using myelin basic protein or histone 2B as substrates. 
No activity was observed (unpublished data). We assayed the 
insoluble/cortical fraction similarly and detected no activity on 
exogenous substrates (unpublished data). We studied Phg2 ac-
tivity indirectly in the cortical fraction by assaying kinase activ-
ity against endogenous substrates by incubating the Triton 
X-100–insoluble pellet with Mg
2+–γ-  [
32P]ATP and comparing 
samples from wild-type and phg2-null cells. We observed a 
single [
32P]O4-labeled band (of  250 kD) in samples from 
wild-type cells that was not observed in samples from phg2-null 
Figure 6.  Regulation of cell adhesion and chemotaxis by 
Phg2. (A) Cell adhesion of phg2 mutants. (B) Chemotaxis of 
phg2-null cells. Cells were traced and analyzed as in Fig. 3 C. 
Superimposed images of representative traces of wild-type 
KAx-3 and phg2-null strains are shown. The superimposed 
images show the cell shape, direction, and length of the path 
at 1-min intervals. (C) Representative frames from chemotaxis 
videos of wild-type cells, phg2-null cells, and phg2-null cells 
expressing GST-Phg2. The inset in the middle panel shows an 
enlargement of two representative cells (arrow). Asterisks indi-
cate the positions of the micropipette containing cAMP. 
(D) DIAS analysis of chemotaxis. (E) Kinetics of F-actin poly-
merization and myosin II assembly in the Triton X-100–insoluble 
cytoskeletal fraction of wild-type cells and phg2-null cells. 
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cells (Fig. 7 A; the remainder of the gel is not depicted). The 
band was barely detectable in samples from unstimulated cells, 
strong in samples from cells stimulated for 10 and 20 s, and 
barely detectable in samples from later time points. As the band 
is not observed in phg2-null cells, we suggest that Phg2 is re-
quired for phosphorylation of the  250-kD protein in this assay. 
The kinase activity is restored in phg2-null cells expressing 
wild-type Phg2 but not GFP-Phg2∆RA, suggesting that the RA 
domain is required for Phg2 activity and that Phg2 activity may 
be activated by Rap1-GTP. Our assay does not distinguish be-
tween Phg2 directly phosphorylating the  250-kD protein or 
being required for the activity of another kinase that directly 
phosphorylates myosin II.
Coomassie blue–stained gels showed that the  250-kD 
phosphorylated protein comigrated with the myosin II band. To 
examine the possibility that the phosphorylated band is myosin II, 
we repeated the assay in mhcA
− cells and found that the band was 
absent (Fig. 7 B). To distinguish between the protein being myosin II 
and it requiring myosin II for its cortical localization, we expressed 
GFP–myosin II in mhcA
− cells. The phosphorylated band was 
then present, and its mobility corresponded to GFP–myosin II 
(Fig. 7 B), indicating that the phosphorylated protein is myosin II. 
This activity was unaffected by pretreatment with LY294002 or 
latrunculin A, which is consistent with our fi  ndings that Phg2 cor-
tical localization is unaffected by the treatment of these drugs and 
indicating that these pathways were not dependent on the PI3K 
pathway or F-actin polymerization (Fig. 7 C).
We then assayed mhcA
− cells expressing myosin II
3XAla or 
myosin II
3XAsp to examine whether Thr
1,823, Thr
1,833, or Thr
2,029 
might be the sites of myosin II phosphorylation. Fig. 7 D illus-
trates that neither of these substituted myosin II proteins are 
phosphorylated. Although these fi  ndings are consistent with 
the sites of Phg2-dependent myosin II phosphorylation being 
Thr
1,823, Thr
1,833, or Thr
2,029, we cannot exclude the possibility 
that Thr
1,823, Thr
1,833, or Thr
2,029 are not the sites of phosphoryla-
tion and that the actual sites of phosphorylation are unavailable 
in myosin II
3XAla and myosin II
3XAsp in our assay for an unknown 
reason. We also investigated myosin II phosphorylation in cells 
lacking three of the four MHCKs (mhck-A/-B/-C–null cells), 
which exhibit an extensive myosin II overassembly (Yumura 
et al., 2005). Fig. 7 E indicates that myosin II phosphorylation 
is highly reduced in this strain, suggesting that the myosin II 
phosphorylation pathway requires MHCK. The overexpression 
of MHCK-A in phg2-null cells suppresses the lack of myosin II 
phosphorylation in our assay (Fig. 7 F). The kinase activity is 
found in unstimulated as well as stimulated cells, with the activ-
ity increasing after stimulation. We fi  nd that as previously re-
ported for wild-type cells (Steimle et al., 2001), MHCK-A 
localizes to the leading edge of chemotaxing phg2-null cells, 
suggesting that the loss of myosin II kinase activity in phg2-null 
cells is not caused by the inability to recruit MHCK-A (unpub-
lished data). Phg2 has a Rap1-GTP–binding RA domain and, 
therefore, is expected to lie downstream from Rap1. Cells ex-
pressing Rap1G12V have an elevated level of myosin II phos-
phorylation that is also extended, which is consistent with 
increased and extended activation mediated by the activated 
form of Rap1 (Fig. 7 G).
Discussion
Rap1 regulates myosin II assembly 
and cell adhesion
We demonstrated that Rap1 is dynamically activated in response 
to chemoattractant stimulation with a Rap1-GTP GFP reporter 
transiently localizing to the cell cortex with a peak at 5–10 s. 
In chemotaxing cells, activated Rap1 is found predominantly at 
Figure 7.  Cortical myosin II phosphorylation 
by Phg2. The cytoskeletal fractions from cells at 
the indicated times after cAMP stimulation 
were assayed for kinase activity (see Materials 
and methods). The reactions were subjected to 
SDS-PAGE and were Coomassie blue stained 
(bottom panel of each ﬁ  gure). The top panel of 
each ﬁ  gure shows an autoradiogram of the gel 
depicted in the bottom panel. Solid arrows 
  indicate the position of myosin II, and open 
  arrows point to bands of unknown composition. 
(A) Assay of wild-type, phg2-null, and phg2-null 
cells expressing Phg2 or Phg2∆RA. (B) Assay 
of mhca-null cells and mhca-null cells express-
ing GFP–myosin II. (C) Assays in which cells 
were pretreated with latrunculin A or LY294002 
for 20 min before stimulation. Control cells were 
treated with DMSO, the solvent for the two 
drugs. (D) mhca-null cells expressing myosin 
II
3XAla or myosin II
3XAsp. (E) mhck-A
−, -B
−, and 
-C
− cells. (F) Cells expressing MHCK-A. (G) 
Rap1
G12V-expressing cells.JCB • VOLUME 176 • NUMBER 7 • 2007  1030
the leading edge of chemotaxing cells with a distribution that 
weakly extends along the cortex toward the posterior, whereas 
total Rap1 is found predominantly on membrane vesicles and 
along the plasma membrane, as in mammalian cells. The spatial 
distribution of Rap1-GTP extends more laterally than that 
of Ras-GTP, and the kinetics of activation are slower, suggest-
ing that the sites of function of Rap1 and Ras overlap but are 
not coincident.
Rap1
G12V cells are very fl  at and adherent to the substra-
tum, which is consistent with fi  ndings in mammalian cells, indi-
cating the involvement of Rap1 in controlling cell shape and 
attachment. These cells chemotax slowly and produce numer-
ous lateral pseudopodia, probably in part because they cannot 
regulate their attachment to the substratum and restrict the acti-
vation of pseudopod formation to the side of the cell closest to 
the chemoattractant source. Rap1
S17N cells have a modest reduc-
tion in attachment. The Rap1
S17N phenotypes are weak, presum-
ably because Rap1
S17N does not effectively inhibit the Rap1 
GEFs, as there is little change in the activation of endogenous 
Rap1 in these cells.
Our studies suggest that one mechanism by which Rap1 
controls cell spreading and attachment in D. discoideum acts 
at least partially through the regulation of myosin II assembly. 
Rap1
G12V cells exhibit weak chemoattractant-mediated myosin II 
assembly, which is consistent with an inability to control cell 
contraction. In response to NaN3 treatment, wild-type but not 
Rap1
G12V cells contract, which is consistent with previous stud-
ies (Pasternak et al., 1989; Kang et al., 2002). These phenotypes 
are shared by cells lacking myosin II (mhcA
− cells) or mhcA
− 
cells expressing myosin II
3XAsp. These strains exhibit a spread, 
fl  at cell shape and a high substratum attachment. In Rap1
G12V cells, 
GFP–myosin II dissociates from the cell cortex in response to 
chemoattractant stimulation but undergoes only a slight and 
greatly delayed reassociation with the cortex. Rap1
G12V cells 
  exhibit an abnormal and deeply reduced chemoattractant-mediated 
myosin II assembly with slow kinetics. These fi  ndings suggest 
that Rap1 negatively controls myosin II assembly.
MHCKs are the major kinases that phosphorylate myosin II 
on Thr
1,823, Thr
1,833, and Thr
2,029 and result in myosin II dis assembly 
(Egelhoff et al., 1993; De la Roche et al., 2002). MHCK-A is 
recruited to the leading edge by binding to F-actin, which acti-
vates the kinase (Egelhoff et al., 2005), thereby disassembling 
myosin II at the site of leading edge protrusion. Our fi  ndings 
that Rap1 is activated at the leading edge and that the expression 
of Rap1
G12V causes extended myosin II disassembly suggest 
that Rap1 may be a key upstream spatial regulator of myosin II 
assembly. We suggest that Rap1 may prevent myosin II assem-
bly at the leading edge and may indirectly (passively) promote 
its assembly at the posterior of cells. Myosin II assembly 
and phosphorylation are regulated by cGMP in D. discoideum 
(Bosgraaf et al., 2002, 2005; Bosgraaf and van Haastert, 2006). 
Cells lacking the cGMP-binding protein GbpC exhibit a spatial-
temporal profi  le of GFP–myosin II cortical disassembly/assem-
bly similar to that of Rap1
G12V cells. The profi  le of myosin II in 
the Triton X-100–insoluble pellet is similar to that of cells lack-
ing both guanylyl cyclases (Bosgraaf et al., 2002, 2005). Thus, 
cells expressing Rap1
G12V exhibit phenotypes similar to those 
lacking cGMP or the cGMP effector GbpC, suggesting that 
Rap1 may be a negative regulator of the cGMP pathway. Just 
before submission of this manuscript, a study by Kortholt et al. 
(2006) demonstrated that GpbD is a Rap1 GEF and that its 
overexpression leads to increased cell adhesion and chemotaxis 
defects similar to those of the Rap1
G12V cell presented here. 
They present evidence that Rap1 lies upstream of Phg2.
Our model by which Rap1 may control anterior and pos-
terior functions may be analogous to the proposed mechanism 
by which anterior and posterior functions are differentially reg-
ulated by Gαi and Gα12/13 in neutrophils (Wong et al., 2006). 
Gαi promotes the leading edge function and inhibits posterior 
function (activation of RhoA and assembly of myosin II), 
whereas Gα12/13 controls posterior functions by mediating 
RhoA activation. The loss of Gαi function increases RhoA ac-
tivity, whereas the inhibition of RhoA function increases lead-
ing edge function, indicating that the regulation of anterior and 
posterior functions is balanced. In D. discoideum, anterior and 
posterior functions have different response kinetics and are spa-
tially restricted in polarized cells (Van Haastert and Devreotes, 
2004; Sasaki and Firtel, 2006). Chemotaxing Rap1
G12V cells of-
ten have a fl  at, extended posterior region that does not lift from 
the substratum, suggesting that Rap1 plays a part in controlling 
the posterior function of moving cells. In addition, the localiza-
tion of myosin II is altered in unstimulated Rap1
G12V compared 
with wild-type cells. Although myosin II has a general localiza-
tion along the cortex except at sites of pseudopod extension 
with an enrichment at the posterior in wild-type cells (Clow and 
McNally, 1999), resting Rap1
G12V cells have a polarized cyto-
skeletal organization with myosin II present in a single, ex-
tended domain along approximately one third of the cortex 
opposite a domain that has the appearance of a projecting 
  lamellipod. In chemotaxing Rap1
G12V cells, myosin II is found 
almost exclusively in a small cap/domain at the posterior of cells, 
as though myosin II sites are restricted from other areas of the 
cell through the constitutive activation of Rap1. This lack of 
visible myosin II along the cell’s lateral sides may contribute to 
a possible loss of myosin II–mediated cortical tension and the 
presence of lateral pseudopodia.
Role of Phg2
We demonstrated that Phg2 is a key regulator of the cell’s cyto-
skeleton and cell attachment. phg2-null cells are highly adhe-
sive, which is a fi  nding that contrasts that of Gebbie et al. (2004). 
We discovered that under two different assay conditions, their 
phg2-null strain has increased adhesion in phosphate buffer, 
suggesting that differences may be caused by assay conditions. 
As phg2-null cells exhibit high adhesion, we suggest that Phg2 
negatively regulates cell adhesion.
Phg2 is required for proper chemotaxis. Chemotaxing 
phg2-null cells move slowly and have a broad leading edge with 
numerous small protrusions. The broad leading edge structure 
(more of a lamellipod than a pseudopod) and protrusions are 
presumably related to the broad lamellipod and fi  lopodia-like 
protrusions exhibited by vegetative phg2-null cells. These cells 
have reduced random motility (Gebbie et al., 2004; unpublished 
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domain, but the ability to complement the null phenotypes does, 
indicating that the genetic function of Phg2 is dependent on 
Phg2’s ability to bind Rap1-GTP. These fi  ndings demonstrate 
that Phg2 and, thus, its putative regulator Rap1 play key roles in 
controlling leading edge formation and in suppressing these lat-
eral and adventitious protrusions. phg2-null cells have a deeply 
reduced F-actin response, which, along with the high attachment 
of these cells, may account for their reduced chemotactic speed.
A further understanding of the possible mechanism by 
which Phg2 controls the cytoskeleton was obtained by examin-
ing the physiological and biochemical phenotypes of phg2-null 
cells. phg2-null cells show an elevated basal level of myosin II 
and F-actin in vegetative and developmentally competent cells, 
which are normal kinetics of chemoattractant-mediated myosin II 
assembly, but show a substantially reduced F-actin polymeriza-
tion response. Motile amoeboid cells (e.g., neutrophils and 
D. discoideum) spatially restrict F-actin polymerization and lead-
ing edge protrusion from myosin II assembly to the opposite 
poles of polarized cells (Van Haastert and Devreotes, 2004; 
  Sasaki and Firtel, 2006; Wong et al., 2006). Myosin II thick fi  la-
ments are partially responsible for cortical tension or rigidity. 
To protrude a pseudopod, cells must disassemble the myosin II 
thick fi  laments at that site. Our imaging data suggest that Phg2 
is required for the disassembly of myosin II thick fi  laments; in 
the absence of Phg2, cells accumulate elevated levels of myosin II 
in the Triton X-100–insoluble fraction. We revealed that Phg2 
is required for in vitro myosin II phosphorylation in a cortical 
fraction in response to chemoattractant stimulation. As this 
phosphorylation is thought to be responsible for myosin II dis-
assembly from the cortex (De la Roche et al., 2002), our com-
bined data suggest that Phg2 is required for effi  cient cortical 
myosin II phosphorylation and disassembly. We suggest that the 
defect in delocalizing myosin II from the cortex that we observe 
in  phg2-null cells may be responsible for the restricted 
  chemoattractant-mediated F-actin response. In Rap1
G12V cells, 
myosin II disassembly is extended, and there is minimal re-
accumulation over a 2-min time frame.
The initial responses observed after a global stimulation 
recapitulate the changes that occur at the leading edge of chemo-
taxing cells. Like other leading edge responses, Rap1 is acti-
vated rapidly at the cortex, and Phg2 translocates to the cortex 
in response to global stimulation. Rap1 is also activated at the 
leading edge, and Phg2 accumulates at this site. We suggest that 
Phg2 is a new component of the rapidly activated leading edge 
regulatory network that, in this case, controls myosin II phos-
phorylation and disassembly at this site. The reduced myosin II 
phosphorylation in mhck-A
−, -B
−, or -C
− cells and constitutive 
activity in MHCK-A
OE cells suggest that this network may regu-
late MHCK-A (or other MHCKs), which localizes to the lead-
ing edge. The higher basal level of myosin II in phg2-null cells 
is consistent with this hypothesis. Phg2 may play other roles, as 
phg2-null cells have many cellular protrusions and extended 
  lamellipodia in resting and chemotaxing cells, phenotypes that 
are not observed in cells lacking myosin II. phg2-null cells 
  exhibit a normal myosin II response when one examines total 
myosin II that associates with the Triton X-100–insoluble fraction 
and are able to contract upon NaN3 treatment. As such, we expect 
that phg2-null cells can assemble and disassemble myosin II 
in other domains of the cell. In conclusion, Rap1 is a major 
regulator of the cytoskeleton in resting cells and cells stimulated 
by chemoattractant or responding to osmotic stress, and it func-
tions, at least in part, to control myosin II through Phg2. There-
fore, Rap1 may be part of the signaling cascade by which 
leading edge and posterior functions of the cell interact to con-
trol cell polarization and coordinate directional movement.
Materials and methods
Materials
We obtained latrunculin A, LY294002, aprotinin, and leupeptin from 
Sigma-Aldrich, anti-myc antibodies from Santa Cruz Biotechnology, Inc., 
glutathione–Sepharose beads from GE Healthcare, and γ-[
32P]ATP from 
MP Biomedicals. Anti-Rap1 antibodies have been described previously 
(Kang et al., 2002). 13-mm nitrocellulose ﬁ  lters (0.22 μm) used for the 
  adhesion assay were obtained from Millipore.
Strains and plasmids
The full coding sequence of the rap1 cDNA was generated by RT-PCR and 
was subcloned into the EcoRI–XhoI site of pSP72. An EcoRI restriction site 
in the 5′ end region of the rap1 gene was removed by substitution of cyto-
sine at nucleotide 18 with thymine without changing the coding of amino 
acids. For GFP- or myc-Rap1 fusion proteins, the EcoRI–XhoI fragments of 
pSP72 were subcloned into the expression vector EXP-4(+) containing 
  either a GFP or myc fragment.
The mutants Rap1
G12V and Rap1
S17N were generated using the Quik-
Change Site-Directed Mutagenesis kit (Stratagene). Because the D. discoi-
deum rap1 gene product contains two additional N-terminal amino acids 
compared with the human rap1 and ras gene products, amino acids were 
numbered according to the consensus alignment of Ras proteins to facili-
tate comparison (Rebstein et al., 1997). GST-RalGDS–Ras-binding domain 
(RBD) was a gift from J.L. Bos (University Medical Center Utrecht, Utrecht, 
Netherlands). For RBD-RalGDS-YFP fusion protein expression, the RBD of 
RalGDS was ampliﬁ  ed by PCR using GST-RB-RalGDS as a template, was 
  ligated to a YFP fragment, and was cloned into the expression vector 
EXP-4(+). All clones were conﬁ  rmed by DNA sequencing.
A phg2 knockout construct was made by inserting the blasticidin re-
sistance cassette into a BamHI site created at nucleotide 595 of the phg2 
cDNA and was used for a gene replacement in the KAx-3 parental strains. 
Randomly selected clones were screened for a gene disruption by PCR, 
which was then conﬁ  rmed by Southern blot analysis and RT-PCR. These 
studies conﬁ  rmed that the knockout strains did not express Phg2 transcripts 
5′ or 3′ to the site of insertion.
A full-length phg2 sequence was obtained by PCR using a series of 
primers and was cloned into pBluescript, sequenced, and subcloned into 
EXP-4(+) plasmids for GFP or GST fusion protein expression. To create a 
GFP-Phg2 construct lacking the RA domain (GFP-Phg2∆RA), two pairs of 
primers were used to amplify the sequence 5′ and 3′ to that encoding the 
RA domain, creating an XbaI site at the junction site. This created an in-
frame deletion of the RA domain. This construct was then subcloned into 
GFP-fused pEXP4 plasmid. The GFP-Phg2∆RA coding region was con-
ﬁ  rmed by sequencing.
The mhca-null mutant strain in the KAx-3 background and MhcA-
GFP plasmids were provided by J.A. Spudich (Stanford University, Palo 
Alto, CA). The myosin VII– and talin A–null cells were obtained from 
M.A. Titus (University of Minnesota, Minneapolis, MN), and DH1-10 and 
phg2-null cells in the DH1-10 background were obtained from P. Cosson 
(Universite de Geneve, Geneva, Switzerland). The myosin heavy chain 
phosphorylation mutant constructs 3XAsp and 3XAla were gifts from T.T. 
Egelhoff (Case Western Reserve University, Cleveland, OH).
Rap1 activation assay
The Rap1-GTP–binding domain of mammalian RalGDS was expressed in 
E. coli as a GST fusion protein as described previously (Franke et al., 
1997). The puriﬁ  ed GST-RalGDS-RBD was used for the detection of acti-
vated Rap1. Log-phase vegetative cells were washed twice and resus-
pended at a density of 5 × 10
6 cells/ml in Na/K phosphate buffer and 
pulsed for 6 h with 30 nM cAMP every 6 min. The cells were collected 
and re  suspended at a density of 2 × 10
7 cells/ml and were treated 
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15 μM cAMP and lysed by mixing with an equal volume of 2× lysis buffer 
(100 mM Tris, pH 7.5, 300 mM NaCl, 50 mM MgCl2, 20% glycerol, 1% 
NP-40, 2 mM DTT, 2 mM vandate, aprotinin, and 5 μg/ml leupeptin) at the 
indicated times. The lysates were centrifuged for 10 min, and the superna-
tants were   incubated with 10 μg GST-RBD on glutathione–Sepharose beads 
at 4°C for 30 min in the presence of 1 mg/ml BSA. The beads were washed 
three times and subjected to SDS-PAGE and Western blot analysis with 
  either an anti-myc mAb or an anti-Rap1 pAb. For control of the input amount 
of total Rap1 proteins, 40 μl of the cells were taken right after lysis of the 
cells and analyzed.
Chemotaxis and image acquisition
Analyses of chemotaxis toward cAMP were performed as described previ-
ously (Park et al., 2004; Sasaki et al., 2004). The images of chemotaxing 
cells were taken at time-lapse intervals of 6 s for 30 min using an inverted 
microscope (TE300; Nikon) with a plan Fluor ELWD 40× NA 0.6 lens and 
a camera (CoolSnap HQ; Roper Scientiﬁ  c). The frames were captured us-
ing MetaMorph software (Molecular Devices), and the data were ana-
lyzed using DIAS software (Soll Technologies; Wessels et al., 1998). Cells 
for analysis were randomly chosen with the requirement that they move for 
at least 15 min without touching another cell and were examined. Differen-
tial interference contrast images were hand traced (10 frames/min for 
15–20 min). At least ﬁ  ve randomly chosen cells were analyzed from each 
of at least three independent experiments performed on separate days.
The quantitation of membrane or cortical localization of GFP fusion 
proteins was performed as described previously (Sasaki et al., 2004) with 
slight modiﬁ  cation. Fluorescence images were obtained using a confocal 
microscope (DM IRE2; Leica) with HCX plan Apo NA 1.40 100× or 63× 
objective lenses (oil CS; Leica) and a camera (EM-CCD or ORCA-ER; 
Hamamatsu Photonics). Images were captured using SimplePCI software 
(Compix Inc., Imaging Systems) and were analyzed using ImageJ software 
(National Institutes of Health). Differential interference contrast images 
were taken with the same equipment but using an ORCA-285 camera 
(Hamamatsu Photonics).
Cell attachment assay
Adhesion assays were performed as described previously (Sun et al., 
2003) with minor modiﬁ   cations. Log-phase growing cells on the plates 
were washed with Na/K phosphate buffer and resuspended at a density 
of 2 × 10
6 cells/ml. The amount of 4 × 10
5 cells in 200 μl were plated 
onto 13-mm circular nitrocellulose ﬁ   lters (Millipore). After 30 min, un-
attached cells were removed by dipping ﬁ  lters into Na/K phosphate buffer. 
Filters were transferred to microcentrifuge tubes ﬁ  lled with 800 μl Na/K 
phosphate buffer and were vortexed for 1 min with a mixer (model 5432; 
Eppendorf) simultaneously. 150 μl of the detached cells from the ﬁ  lters 
were plated onto a 30-mm Petri plate with a hole covered by a 0.17-mm 
glass coverslip, and an additional coverslip was placed on top. The cells 
were photographed and counted (detached cell number). To determine the 
total cell number, 200 μl of the cells was transferred into microcentrifuge 
tubes ﬁ  lled with 600 μl Na/K phosphate buffer and counted. Cell adhe-
sion is presented as a percentage of detached cells compared with total 
cells. This experiment was repeated three times or more, each time with 
four ﬁ  lters for each strain.
Cytoskeleton kinase activity assay
5 × 10
6 cells/ml in Na/K phosphate buffer were pulsed and stimulated 
with cAMP as described in the PKB/Akt activity assay (Meili et al., 1999). 
After stimulation with cAMP, the cells were lysed by mixing with an equal 
volume of 2× lysis buffer. The cytoskeleton fractions were isolated by cen-
trifugation of the lysates at 4°C for 10 min. The pellets were washed once 
with 1× lysis buffer and then with kinase buffer (25 mM MOPS, pH 7.4, 
25 mM β-glycerophosphate, 20 mM MgCl2, and 1 mM DTT). The pellets 
were resuspended and incubated in 50 μl of kinase buffer containing 
10 μCi γ-[
32P]ATP and 5 μM ATP for 20 min at 22°C. The reaction was 
stopped by the addition of 25 μl of 4× sample buffer followed by SDS-
PAGE. The gels were stained with Coomassie blue, dried on a Hoefer slab 
gel drying apparatus, and exposed to ﬁ  lm.
Biochemical assays
F-actin polymerization and myosin II assembly were assayed as described 
previously (Park et al., 2004). Fluid-phase endosomes were labeled using 
70,000-Mr TRITC-dextran (Sigma-Aldrich). Log-phase cells expressing GFP-
Rap1 proteins were incubated with 0.75 mg/ml TRITC-dextran for 1 h and 
were washed twice with Na/K phosphate buffer. The cells were observed 
using a confocal microscope (DM IRE2; Leica). Sodium azide treatment of 
cells was performed as described previously (Pasternak et al., 1989). Veg-
etative cells were washed twice with MES buffer (20 mM MES, pH 6.8, 
2 mM MgSO4, and 0.2 mM CaCl2) and oxygenated by bubbling for 20 min. 
The cells were allowed to adhere to glass coverslips for 10 min and were 
inverted onto a plate with a hole covered by a glass coverslip holding 150 μl 
MES buffer with or without 25 μM NaN3. After 30 min of incubation, the 
cells were photographed.
Online supplemental material
Fig. S1 shows that the phg2-null strain created in the KAx-3 back-
ground exhibits strong attachment both in the plate-shaking method 
described in Kortholt et al. (2006) and in the cell attachment assay de-
scribed in Materials and methods. Fig. S2 shows an increased number 
of turns and more frequent extrusion of lateral pseudopodia in cells ex-
pressing Rap1
G12V. Fig. S3 shows that the multicellular development of 
Rap1
OE and Rap1
G12V cells is delayed. In contrast, Rap1
S17N cells develop 
more rapidly than wild-type cells. Fig. S4 shows basal levels of F-actin and 
assembled myosin II in vegetative cells or in aggregation-competent 
cells. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200607072/DC1.
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